In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles

Aims: This study aims to explore non-invasive imaging of atherosclerotic plaque through magnetic resonance imaging (MRI) and near-infrared fluorescence (NIRF) by using profilin-1 targeted magnetic iron oxide nanoparticles (PF1-Cy5.5-DMSA-Fe3O4-NPs, denoted as PC-NPs) as multimodality molecular imaging probe in murine model of atherosclerosis. Methods and Results: PC-NPs were constructed by conjugating polyclonal profilin-1 antibody and NHS-Cy5.5 fluorescent dye to the surface of DMSA-Fe3O4-nanoparticles via condensation reaction. Murine atherosclerosis model was induced in apoE-/- mice by high fat and cholesterol diet (HFD) for 16 weeks. The plaque areas in aortic artery were detected with Oil Red O staining. Immunofluorescent staining and Western blot analysis were applied respectively to investigate profilin-1 expression. CCK-8 assay and transwell migration experiment were performed to detect vascular smooth muscle cells (VSMCs) proliferation. In vivo MRI and NIRF imaging of atherosclerotic plaque were carried out before and 36 h after intravenous injection of PC-NPs. Oil Red O staining showed that the plaque area was significantly increased in HFD group (p<0.05). Immunofluorescence staining revealed that profilin-1 protein was highly abundant within plaque in HFD group and co-localized with α-smooth muscle actin. Profilin-1 siRNA intervention could inhibit VSMCs proliferation and migration elicited by ox-LDL (p<0.05). In vivo MRI and NIRF imaging revealed that PC-NPs accumulated in atherosclerotic plaque of carotid artery. There was a good correlation between the signals of MRI and ex vivo fluorescence intensities of NIRF imaging in animals with PC-NPs injection. Conclusion: PC-NPs is a promising dual modality imaging probe, which may improve molecular diagnosis of plaque characteristics and evaluation of pharmaceutical interventions for atherosclerosis.

[1]  M. Schwaiger,et al.  MRI of Coronary Wall Remodeling in a Swine Model of Coronary Injury Using an Elastin-Binding Contrast Agent , 2011, Circulation. Cardiovascular imaging.

[2]  Ralph Weissleder,et al.  Hybrid In Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis With Customized Nanosensors , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Shi Ke,et al.  Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. , 2007, Journal of biomedical optics.

[4]  Mark A. Eckert,et al.  Novel Molecular and Nanosensors for In Vivo Sensing , 2013, Theranostics.

[5]  Kai Jiang,et al.  Dual-Modal Magnetic Resonance and Fluorescence Imaging of Atherosclerotic Plaques in Vivo Using VCAM-1 Targeted Tobacco Mosaic Virus , 2014, Nano letters.

[6]  Gao-Jun Teng,et al.  Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome , 2013, The International Journal of Cardiovascular Imaging.

[7]  Yong Ho Bae,et al.  Molecular insights on context-specific role of profilin-1 in cell migration , 2012, Cell adhesion & migration.

[8]  René M. Botnar,et al.  Molecular MRI of Atherosclerosis , 2013, Molecules.

[9]  Rubel Chakravarty,et al.  Nanobody: The “Magic Bullet” for Molecular Imaging? , 2014, Theranostics.

[10]  René M. Botnar,et al.  Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. , 2007, Journal of the American College of Cardiology.

[11]  J. Penninger,et al.  Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways , 2013, Regulatory Peptides.

[12]  F. Jaffer,et al.  The advancing clinical impact of molecular imaging in CVD. , 2013, JACC. Cardiovascular imaging.

[13]  Sang-Wuk Jeong,et al.  Molecular Imaging of Cathepsin B Proteolytic Enzyme Activity Reflects the Inflammatory Component of Atherosclerotic Pathology and Can Quantitatively Demonstrate the Antiatherosclerotic Therapeutic Effects of Atorvastatin and Glucosamine , 2009, Molecular imaging.

[14]  Kluwer Academic Publishers.  The international journal of cardiovascular imaging , 2001 .

[15]  A. Zernecke,et al.  Molecular Imaging of Inflammation in Atherosclerosis , 2013, Theranostics.

[16]  René M. Botnar,et al.  Three-Dimensional Black-Blood Cardiac Magnetic Resonance Coronary Vessel Wall Imaging Detects Positive Arterial Remodeling in Patients With Nonsignificant Coronary Artery Disease , 2002, Circulation.

[17]  Yuliya Vengrenyuk,et al.  Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression. , 2013, JACC. Cardiovascular imaging.

[18]  D. Eitzman,et al.  Acute myocardial infarction leads to acceleration of atherosclerosis. , 2013, Atherosclerosis.

[19]  René M. Botnar,et al.  140 Molecular MRI of vascular remodeling in a swine model of coronary injury using an elastin-binding contrast agent , 2008 .

[20]  S. Shoelson,et al.  Profilin-1 Haploinsufficiency Protects Against Obesity-Associated Glucose Intolerance and Preserves Adipose Tissue Immune Homeostasis , 2013, Diabetes.

[21]  M. Budoff,et al.  Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. , 2012, European heart journal.

[22]  R. Gibbs,et al.  Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI. , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[23]  Mohammad T Elnakish,et al.  Vascular Remodeling–Associated Hypertension Leads to Left Ventricular Hypertrophy and Contractile Dysfunction in Profilin-1 Transgenic Mice , 2012, Journal of cardiovascular pharmacology.

[24]  P. Perret,et al.  In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE-/-mice using VCAM-1-Specific , 99 m Tc-Labeled Peptidic Sequences , 2013 .

[25]  T. V. van Berkel,et al.  Scavenger Receptor-AI–Targeted Iron Oxide Nanoparticles for In Vivo MRI Detection of Atherosclerotic Lesions , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[26]  A. Kazlauskas,et al.  Attenuated Expression of Profilin-1 Confers Protection From Atherosclerosis in the LDL Receptor–Null Mouse , 2007, Circulation research.

[27]  R. Krams,et al.  Atherosclerosis: cell biology and lipoproteins - new developments in imaging of inflammation of the vulnerable plaque. , 2008, Current opinion in lipidology.